Violich Capital Management’s Biogen BIIB Stock Holding History

Violich Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-725	Closed	-$218K	–	114
2018 Q4	$218K	Hold	725	–	–	0.06%	101
2018 Q3	$256K	Hold	725	–	–	0.06%	103
2018 Q2	$210K	Buy	+725	New	+$204K	0.05%	112
2018 Q1	–	Sell	-725	Closed	-$231K	–	116
2017 Q4	$231K	Hold	725	–	–	0.06%	105
2017 Q3	$227K	Buy	+725	New	+$215K	0.06%	102

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Violich Capital Management's BIIB Position: Q1 2019 in Review

Violich Capital Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 725 shares — an estimated $218K sold.

Violich Capital Management first reported a position in BIIB in Q3 2017 and held it in 5 quarters. The position peaked at $256K in Q3 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

Violich Capital Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
Violich Capital Management sold 725 Biogen shares in Q1 2019, an estimated $218K.
Violich Capital Management first reported a position in Biogen in Q3 2017 and held it in 5 quarters.
Violich Capital Management's Biogen position peaked at $256K in Q3 2018.
1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Violich Capital Management's 13F filing for Q1 2019, filed 7 May 2019.